

UPDATE: Indivior notes robust results for treatment in fentanyl trial


CORRECT: Indivior notes results for painkiller in fentanyl trial


Indivior's painkiller demonstrates positive interaction with fentanyl


(Sharecast News) - Pharmaceutical company Indivior hailed the results of a study aimed at assessing the ability of its buprenorphine asset to reduce r...


EXECUTIVE CHANGES: Dechra Pharmaceuticals picks Alison Platt as chair


LONDON MARKET MIDDAY: Stocks rise as investors eye US inflation data


IN BRIEF: Scopia sells 2.8% stake in Indivior for GBP50 million


(Sharecast News) - Indivior was under the cosh on Wednesday after US alternative asset management firm Scopia Capital sold 20m shares in the opioid ad...